Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 20, 1999

View Archived Issues

Alexion advances MI product, UniGraft

ImClone Systems files IND in U.S. for antiangiogenic agent

Progress in proceedings concerning Celltech Chiroscience and Medeva merger

Pivotal trials of Optison ultrasound imaging agent begin in Japan

Pharmos seeks approval for Loterox in the U.K.

Genentech's rhuMAb-VEGF will move to phase III study

WHO takes over to ensure continued availability of antitrypanosomal agent

Searle patents new series of p38 MAP kinase inhibitors for inflammation

Another megamerger proposed: Pharmacia & Upjohn and Monsanto

Nonpeptide agents which mimic peptide T binding to CD4 cell receptors as new treatments for HIV

Synthetic immunogens useful for preparation of HPV preventive vaccine

Preclinical studies validate Nabi's novel approach to treating and preventing nicotine addiction

Novel dopaminergic agents synthesized and tested at AHP

Inhibitors of CPT-I from Sigma-Tau useful for hyperglycemic states, cardiovascular disorders

Roberts launches emergency contraceptive in Canada

Glaxo Wellcome files for approval of first triple combination anti-HIV therapy

PPG superior to nonselective mGluR agonists in audiogenic seizure model

Phase I clinical trial initiated with OSI's second anticancer agent

Remacemide for resistant epilepsy: preliminary data from meta-analysis

German launch announced for flu drug

New class I mGluR antagonist prevents seizure-induced hippocampal damage

Swiss regulatory authorities grant Visudyne Therapy its first approval

Add-on stiripentol produces high response rate in intractable epilepsy syndrome

Tetrapeptide with potent antiinflammatory, antiarthritic effects emerges from India

Warner-Lambert files IND for oral calcitonin product for osteoporosis

New antiplatelet pyridazinones presented by Chinese university investigators

Benzimidazole antidiabetic agent advances through the pipeline in Japan and overseas

NicOx commences phase IIa trial with treatment for Paget's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.